KeyCorp Brokers Lift Earnings Estimates for Addus HomeCare

Addus HomeCare Co. (NASDAQ:ADUS) – Research analysts at KeyCorp lifted their FY2024 earnings estimates for shares of Addus HomeCare in a research report issued to clients and investors on Monday, January 6th. KeyCorp analyst M. Gillmor now expects that the company will earn $4.52 per share for the year, up from their previous forecast of $4.50. KeyCorp currently has a “Strong-Buy” rating on the stock. The consensus estimate for Addus HomeCare’s current full-year earnings is $4.59 per share. KeyCorp also issued estimates for Addus HomeCare’s Q1 2025 earnings at $1.14 EPS, Q2 2025 earnings at $1.31 EPS, Q3 2025 earnings at $1.34 EPS, Q4 2025 earnings at $1.47 EPS and FY2025 earnings at $5.26 EPS.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. During the same quarter in the previous year, the firm earned $1.03 earnings per share. The business’s quarterly revenue was up 7.1% compared to the same quarter last year.

Other analysts also recently issued reports about the stock. Macquarie reaffirmed an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. StockNews.com raised Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Royal Bank of Canada reissued an “outperform” rating and set a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. Stephens raised their target price on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Finally, Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. One investment analyst has rated the stock with a sell rating, nine have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $133.67.

Addus HomeCare Stock Up 0.6 %

Shares of Addus HomeCare stock opened at $126.42 on Thursday. Addus HomeCare has a 12-month low of $85.94 and a 12-month high of $136.12. The stock has a market capitalization of $2.29 billion, a P/E ratio of 28.93, a PEG ratio of 2.11 and a beta of 1.00. The stock has a 50 day moving average price of $125.00 and a two-hundred day moving average price of $125.95.

Hedge Funds Weigh In On Addus HomeCare

Several institutional investors have recently bought and sold shares of the business. Quarry LP bought a new stake in shares of Addus HomeCare during the third quarter worth $28,000. Quest Partners LLC acquired a new position in Addus HomeCare during the 2nd quarter worth about $31,000. Farther Finance Advisors LLC lifted its position in Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after buying an additional 366 shares in the last quarter. Sandia Investment Management LP bought a new stake in Addus HomeCare during the 2nd quarter worth about $58,000. Finally, GAMMA Investing LLC increased its position in Addus HomeCare by 25.7% in the 3rd quarter. GAMMA Investing LLC now owns 935 shares of the company’s stock valued at $124,000 after acquiring an additional 191 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

Insider Activity

In related news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the transaction, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 39,750 shares of company stock worth $4,930,750. Corporate insiders own 4.60% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.